Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|38|4374-4404

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.38, 2014-12, pp. : 4374-4404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents

By Laird A Douglas   Cherrington Julie M  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 51-64

Informa Healthcare

Access to resources Recommend Favorite

Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 7, 2011-06 ,pp. : 611-624

Bentham Science Publishers

Access to resources Recommend Favorite

Development for Anticancer Therapy: Small-Molecule Inhibitors Targeting Protein Kinase B

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-01 ,pp. : 1272-1294

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

By Marks Paul A  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1049-1066

Informa Healthcare

Access to resources Recommend Favorite

Small-Molecule BET Inhibitors in Clinical and Preclinical Development and Their Therapeutic Potential

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 8, 2015-04 ,pp. : 776-794

Bentham Science Publishers

Access to resources Recommend Favorite